Invesaro

Stocks Health care CV

NASDAQ · Health care

CapsoVision, Inc (CV)

CapsoVision, Inc brought in $13.9M of revenue over the twelve months to June 30, 2026. It posted a net loss of $29.8M. In fiscal 2025 capital spending exceeded operating cash flow by $23M. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

Free, no password. An email when CV files with the SEC.

Price
$6.44
+1.90% on the day · November 9, 2026
52-week range $4.50 to $15.37
Market cap
$322.3M
Revenue (last 12 months)
$13.9M
Net margin
-214.7%

Key facts about CapsoVision, Inc

Net worth
CapsoVision, Inc has a market value (market cap) of $322.3M at the latest share price, and shareholders' equity of $13.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $13.6M (+15.3% year on year), with a net loss of $25.3M. Over the 12 months to June 30, 2026: revenue $13.9M, net loss $29.8M.
Cash flow
In fiscal 2025 operations used $22.9M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
CapsoVision, Inc's next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What CapsoVision, Inc does

CapsoVision, Inc is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker CV.

Revenue and profit by year

Revenue
FY25: $11.8M $11.8M FY25FY25: $13.6M $13.6M FY25
Net income
FY25: -$19.9M -$19.9M FY25FY25: -$25.3M -$25.3M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$13.6M-$25.5M-$25.3M-$1.03-$23M
2025$11.8M-$19.9M-$19.9M-$9.85-$20.2M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around November 12, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 13, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where CV ranks in Health care

Revenue$13.6M
#502 of 751 in Health care · Bottom 33%
Revenue growth+15.3%
#228 of 532 in Health care · Top 43%
Net margin-186.8%
#476 of 544 in Health care · Bottom 13%
Free cash flow margin-169.4%
#431 of 490 in Health care · Bottom 12%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What CapsoVision, Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 4, 2026
  2. September 28, 2026
  3. September 18, 2026
    Material agreement8-KCapsoVision entered into a securities purchase agreement to raise approximately $18 million in a registered direct offering.
  4. August 18, 2026
  5. August 13, 2026
  6. August 13, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 9.9% to $3.6M versus the same quarter last year; diluted EPS -$0.15 versus -$2.02.
  7. August 13, 2026
  8. July 2, 2026
  9. June 12, 2026
  10. May 14, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue was flat at $2.8M versus the same quarter last year; diluted EPS -$0.15 versus -$2.49.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 23, 2026. Insider transactions on SEC

Insider trades

What the people running CapsoVision, Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders bought $15M worth of shares on the open market in the last 90 days and sold none.

Bought (open market)
$15M
last 90 days
Sold
$0
last 90 days
Net bought
2,636,203
$15M
DateInsiderWhatSharesPriceValueFiling
September 18, 2026 Harari Eliyahou Et Al10% owner Boughtindirect 878,735 $5.69 $5M Form 4
September 18, 2026 Harari Eliyahou Et Al10% owner Boughtindirect 878,734 $5.69 $5M Form 4
September 15, 2026 Shen Ching Hang10% owner Boughtindirect 878,734 $5.69 $5M Form 4
July 17, 2026 Harari Eliyahou Et Al10% owner Boughtindirect 61,068 $6.73 $411K Form 4
July 8, 2026 Harari Eliyahou Et Al10% owner Boughtindirect 81,300 $6.09 $495.1K Form 4
June 30, 2026 Gouw Julia SDirector Exercised options 2,022 $7.58 $15.3K Form 4
June 30, 2026 Tsai Chen LungDirector Exercised options 2,022 $7.58 $15.3K Form 4
June 30, 2026 Harari MicheleDirector Exercised options 2,022 $7.58 $15.3K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns CV

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Shen Ching Hang13G, passive with 1 related filers 12.8% 6,400,527 April 15, 2026
Eliyahou Harari13G, passive with 2 related filers 10.2% 5,100,867 May 6, 2026
Kioxia Corporation13G, passive with 1 related filers 7.4% 3,446,925 November 12, 2025

Latest filings below 5%: CID Greater China Venture Capital Fund III, L.P. 0% (April 7, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 50 managers reported a position.

HolderSharesValueChange on quarter
BlackRock, Inc.1,896,088$14.4M+591,667
Vanguard Capital Management LLC1,058,468$8M+32,199
Geode Capital Management, LLC578,482$4.4M+143,328
State Street Corp410,241$3.1M+154,200
Vanguard Portfolio Management LLC240,425$1.8M+76,039
Northern Trust Corp220,095$1.7M+67,761
Vanguard Fiduciary Trust Co103,630$785.5K+14,998
Charles Schwab Investment Management Inc79,360$601.5K+17,983
Bank of New York Mellon Corp75,021$568.7K+25,727
Nuveen, LLC46,011$348.8K+12,913
Deutsche Bank AG\34,700$263K+9,411
XTX Topco Ltd31,845$241.4K-35,536
Wells Fargo & Company31,820$241.2K+21,575
Bank of America Corp25,469$193.1K+3,231
Rhumbline Advisers21,969$166.5K+8,837
MetLife Investment Management, LLC21,114$160K+4,408
Invesco Ltd.18,827$142.7Knew
Morgan Stanley18,723$141.9K+3,787
Goldman Sachs Group Inc18,627$141.2K-17,484
Citigroup Inc16,384$124.2K+15,981

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

9 insiders reported holding 8,380,846 shares in total, about $54M at the last price.

HolderSharesAs of
Shen Ching Hang10% owner 7,279,2617,279,261 held indirectly September 15, 2026
Harari Eliyahou Et Al10% owner 878,734878,734 held indirectly September 18, 2026
Atkinson Douglas PatrickHead of Global Sales 107,357 May 5, 2026
Harari MicheleDirector 61,065 June 30, 2026
King Wen-Herng HenryDirector 25,619 June 30, 2026
Kuo Hui YingDirector 15,263 June 30, 2026
Tsai Chen LungDirector 4,929 June 30, 2026
Gouw Julia SDirector 4,909 June 30, 2026
Imperial Joanne CarolDirector 3,709 June 30, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about CV

What does CapsoVision, Inc do?

CapsoVision, Inc is a company in the Health care sector, listed on NASDAQ as CV. Its shares trade on NASDAQ under the ticker CV.

What is CapsoVision, Inc's net worth?

CapsoVision, Inc has a market value (market cap) of $322.3M at the latest share price, and shareholders' equity of $13.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is CapsoVision, Inc profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $29.8M on revenue of $13.9M.

How much revenue does CapsoVision, Inc make?

Over the twelve months to June 30, 2026 CapsoVision, Inc reported revenue of $13.9M.

When did CapsoVision, Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from November 4, 2026.

When is CapsoVision, Inc's next earnings report?

CapsoVision, Inc's next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare CV with

Compare CV with any company

Follow CV

Get an email when CapsoVision, Inc files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when CV files with the SEC.

Where the numbers come from

Financial figures are the values CapsoVision, Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.